Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Drug-resistant profiles of extracellular vesicles predict therapeutic response in TNBC patients receiving neoadjuvant chemotherapy

Fig. 5

(a) Distribution of clinical variables and drug-resistant EV markers in patients with TNBC who underwent NAC. (b) Comparison of the MFI values for drug-resistant EV markers between patients with TNBC who responded to NAC and patients with TNBC who were resistant to NAC. Data are expressed as MFI in arbitrary units (a.u.) and represents the mean ± SEM of 20 individuals in each group. Statistical analysis was performed using the Welch’s t-test. (c) ROC curves for the three drug-resistant EV markers

Back to article page